3Pincus T, Callahan LF. What is the natural history of rheumatoid arthritis? Rheum Dis Clin North Am, 1993,19(1): 123.
4Sasso EH, Merrill C, Furst TE. Immunoglobulin binding properties of the Prosorba immunadsorption column in treatment of rheumatoid arthritis. Ther Apher, 2001,5 (2): 84.
5Matic G,Bosch T, Ramlow W. Background and indications for protein A-based extracorporeal immunoadsorption. Ther Apher, 2001,5(5) :394.
6Schneidewind-Muller JM, Winkler RE, Tiess M, et al. Change in lymphocytic cluster distribution during extracorporeal immunoadsorption. Artif Organs ,2002,26(2): 140.
7Hehmke B, Salzsieder E, Matic GB, et al. Immunoadsorption of immunoglobulinsalters intracytoplasmic type 1 and type 2 T cell cytokine production in patients with refractory autoimmune disease.Ther Apher, 2000,4 (4): 296.
8Murphy RM,Colton CK, Yarmish ML. Staphylococcal protein A in neoplastic disease: Analysis of physiochemical aspects. Mol Biother,1989,1(4) :186.
9Levy J,Degani N. Correcting Immune Imbalance: The Use of Prosrba Column Treatment for Immune Disorders. Therapeutic Apheresis and Dialysis ,2003,7(2) :197.
10Mugnier B, Poullin P, Lefevre P, et al. Clinical improvement in a patient with severe rheumatoid arthritis and chronic hepatitis B after prosorba column immunoadsorption: a one-year followup.Arthritis Rheum, 2003,49(5): 722.
二级参考文献23
1David C, Kluth,Andrew J. Anti-glomerular basement membrane disease. J Am Soc Nephrol, 1999, (10) :2446.
2Lockwood CM, Rees AJ,Pearson TA et al. Immunosuppression and plasma exchage in the treatneat of Goodpasture's syndrome.Lancet, 1976,1:711.
3Pusey CD, Rees AJ, Evans DJ et al. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int, 1991,40: 757.
4Alan DS,Jeremy BL, Liz L et al. Goodpasture's disease.Lancet,2001,358:917.
5Frank M, Kai-Olaf N, Oliver G et al. Thearapeutic options for critically ill patients suffering frown progressive lupus nephritis or Goodpasture's syndrome.Kidney Int, 1998,53(Suppl 64) :S31.
6Bygren P, Christian F, Tore L et al. Goodpasture's syndrome treated with staphylococcal protein A immunoadsorption. Lancet, 1985,2(8467) : 1295.
7Esnault VL,Testa A, Jayne DR et al. Influence of immunoadsorption on the removal of immunoglobulin G autoantibodies in crescentic glomerulonepbritis. Nephron, 1993,65 : 180.
8Moreso F, Poveda R, Gil-Vernet S et al. Therapeutic immunoadsorption in Goodpasture disease. Med Clin (Barc), 1995,105(2) :59.
9Klaus L, Sylvia K,Kurt D et al. Immunoadsorption in Goodpasture's syndrome.Am J Kidney Dis,2000,36(2) :392.
10Turner AN, Rees AJ. Antiglomerular basement membrane disease. In:Davison AN, Cameron JS, Grunfeld J-P et al. Oxford Textbook of Nephrology: Oxford University Press, 1998,645.
4Sutton B, Corper A, Bonagure V, et al. The structure and origin of rheumatoid factors [J]. Immunology Today, 2000, 21(4): 177- 183.
5Furst D, Felson D, Thoren G, et al. Immunoadsorption for the treatment of rheumatoid arthritis: final results of a randomized trial prosorba trial investigators [J]. Ther Apher, 2000, 4(5): 363- 373.
6Hailey D, Topfer LA. Extraeorporeal immunoadsorption treatment for rheumatoid arthritis [ J ]. Issues Emerg Health Technol, 2002, (28): 1-4.
7Pounin P, Announ N, Mugnier B, et al. Protein Aimmunoadsorption (Prosorba column) in the treatment of rheumatoid arthritis [J]. Joint Bone Spine, 2005, 72(2): 101 - 103.
8Deodhar A, Alien E, Daoud K, et al. Vasculitis secondary to staphylococcal Protein A immunoadsorption (Prosorba column ) treatment in rheumatoid arthritis [ J ]. Semin Arthritis Rheum, 2002, 32(1): 3-9.
9Wang Ying, Huang Wenqiang, Wang Zheng, et al. Preparation and characterization of high loading porous crosslinked poly ( vinyl alcohol) resins [J]. Polymer, 2004, 45:71- 77.
10Wang Shenqi, Yu Yaoting, Cui Tao, et al. A novel amphiphilic adsorbent for the removal of low-density lipoprotein [ J ]. Biomaterials, 2003, 24(16) :2799- 2802.
